M Holdings Securities, Inc. Abb Vie Inc. Transaction History

M Holdings Securities, Inc.

$398 Million
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $3.01 Million - $3.52 Million	19,469 New	19,469 $3.33 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $48,710 - $54,859	-354 Reduced 2.25%	15,391 $2.39 Million
Q3 2023 Feb 14, 2024	BUY	$133.59 - $154.65 $1.43 Million - $1.65 Million	10,685 Added 211.17%	15,745 $2.35 Million
Q2 2023 Sep 26, 2023	SELL	$132.51 - $164.9 $1.94 Million - $2.42 Million	-14,652 Reduced 74.33%	5,060 $682,000
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $71,581 - $82,437	-495 Reduced 2.45%	19,712 $3.14 Million
Q4 2022 Feb 10, 2023	BUY	$138.31 - $165.87 $15,352 - $18,411	111 Added 0.55%	20,207 $3.27 Million
Q3 2022 Nov 16, 2022	BUY	$134.21 - $153.93 $19,728 - $22,627	147 Added 0.74%	20,096 $2.7 Million
Q2 2022 Aug 16, 2022	BUY	$137.62 - $174.96 $28,349 - $36,041	206 Added 1.04%	19,949 $3.06 Million
Q1 2022 May 24, 2022	BUY	$131.98 - $163.75 $340,508 - $422,475	2,580 Added 15.03%	19,743 $3.2 Million
Q2 2021 Aug 19, 2021	SELL	$105.21 - $117.21 $48,501 - $54,033	-461 Reduced 2.62%	17,163 $1.93 Million
Q1 2021 May 12, 2021	BUY	$102.3 - $112.62 $18,618 - $20,496	182 Added 1.04%	17,624 $1.91 Million
Q4 2020 Feb 26, 2021	BUY	$80.49 - $108.67 $72,521 - $97,911	901 Added 5.45%	17,442 $1.87 Million
Q3 2020 Nov 16, 2020	BUY	$85.91 - $100.83 $102,490 - $120,290	1,193 Added 7.77%	16,541 $1.45 Million
Q2 2020 Aug 21, 2020	SELL	$73.37 - $98.18 $1.01 Million - $1.35 Million	-13,722 Reduced 47.2%	15,348 $1.51 Million
Q1 2020 May 13, 2020	BUY	$64.5 - $97.79 $830,179 - $1.26 Million	12,871 Added 79.46%	29,070 $2.22 Million
Q4 2019 Feb 10, 2020	SELL	$72.13 - $90.25 $58,136 - $72,741	-806 Reduced 4.74%	16,199 $1.43 Million
Q3 2019 Nov 04, 2019	BUY	$62.98 - $75.72 $85,526 - $102,827	1,358 Added 8.68%	17,005 $1.29 Million
Q2 2019 Aug 16, 2019	SELL	$65.7 - $83.98 $1.73 Million - $2.22 Million	-26,384 Reduced 62.77%	15,647 $1.14 Million
Q1 2019 May 17, 2019	BUY	$77.14 - $90.79 $2.42 Million - $2.84 Million	31,332 Added 292.85%	42,031 $3.39 Million
Q4 2018 Feb 15, 2019	SELL	$77.85 - $96.01 $12,144 - $14,977	-156 Reduced 1.44%	10,699 $986,000
Q3 2018 Nov 16, 2018	BUY	$88.91 - $98.84 $6,668 - $7,413	75 Added 0.7%	10,855 $1.03 Million
Q2 2018 Aug 17, 2018	SELL	$89.78 - $106.23 $13,556 - $16,040	-151 Reduced 1.38%	10,780 $999,000
Q1 2018 May 18, 2018	SELL	$92.01 - $123.21 $29,903 - $40,043	-325 Reduced 2.89%	10,931 $1.04 Million
Q4 2017 Feb 15, 2018	BUY	$89.56 - $98.21 $537 - $589	6 Added 0.05%	11,256 $514,000
Q3 2017 Nov 15, 2017	BUY	$69.85 - $89.22 $16,764 - $21,412	240 Added 2.18%	11,250 $1 Million
Q2 2017 Aug 22, 2017	BUY	N/A	11,010	11,010 $798,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M Holdings Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on M Holdings Securities, Inc. with notifications on news.

Account